Chisys®
WebParticularly significant evidence supporting chitosan as an adjuvant for nasal vaccination comes from clinical investigations on a norovirus vaccine; this demonstrated the ability of … WebJul 1, 2011 · ChiSys is a bioadhesive technology developed to increase the time that drugs reside on mucosal membranes and increases bioavailability, which the firm maintains …
Chisys®
Did you know?
WebSep 15, 2008 · The intellectual property acquired will allow Archimedes to significantly extend the applicability of ChiSys®, Archimedes' highly effective proprietary chitosan … WebMay 22, 2008 · Archimedes uses chitosan in its ChiSys delivery platform to increase the residency time of certain macromolecular and hydrophilic medications at mucosal surfaces, thereby enhancing their absorption characteristics. The firm hopes that the licensed technology will broaden the range of diseases to which ChiSys can be applied.
WebJan 1, 2014 · ChiSys®, a chitosan-based delivery platform, has shown potential in preclinical and clinical investigations as an adjuvant for a variety of intranasally … WebSep 8, 2009 · ChiSys, an innovative drug delivery technology which enhances the residence time of molecules on mucosal membranes, has proven potential for vaccine delivery. Pre-clinical and clinical studies of nasally administered vaccines have demonstrated enhanced immune response. PecSys™ is Archimedes’ patented drug delivery system built around …
WebNov 4, 2015 · ChiSys™ is a drug delivery technology based on chitosan, which is provided by Archimedes Development Limited. In Phase I clinical studies, two randomized, double … Web• Managed analytical and stability programs for Chisys™ Team Leader, Preclinical Development ViroPharma Incorporated Mar 2001 - Aug 2002 1 year 6 months. Exton, PA • Directed all analytical ...
WebMay 1, 2006 · Rabbits were vaccinated intranasally with PA-based vaccines formulated as dry powders with or without chitosan (ChiSys, Archimedes Development Limited), a compound that exhibits muco-adhesive properties, or as a liquid. Formulations also contained MPL adjuvant and PA. Some vaccines contained PA conjugated to a 10-mer …
WebFeb 4, 2014 · ChiSys®, a chitosan-based delivery platform, has shown potential in preclinical and clinical investigations as an adjuvant for a variety of intranasally … northern and central electrical ormskirkWebChiSys® is the proprietary name given by Archimedes Development Limited to its suite of intellectual property relating to the mucosal delivery of therapeutic agents using chitosan … northern ancient mesopotamia geographyWebAug 10, 2024 · The researchers tested the technology on mice and non-human primates and found that the vaccine generated strong immune responses, paving the way for … northern and eastern formularyWebNov 5, 2024 · The CHISYS trademark was assigned an Application Number # 002029056 – by the European Union Intellectual Property Office (EUIPO). Trademark Application Number is a unique ID to identify the CHISYS mark in EUIPO. The CHISYS mark is filed in the category of Medical Instrument Products, Computer & Software Services & Scientific … how to rewind a pull starter ropeWebNov 5, 2024 · The CHISYS trademark was assigned an Application Number # 002029056 – by the European Union Intellectual Property Office (EUIPO). Trademark Application … how to rewind a tape measureWebChitosan is a linear polysaccharide commercially produced by the deacetylation of chitin. It is non-toxic, biodegradable, biocompatible, and acts as a bioadhesive with otherwise … northern and central wiganWebChisys - sentimental channel dedicated to romantic anime and related tops. but also, here you will find not obvious theories on popular anime and interesting anime tests. how to rewind a stanley tape measure